PORTLAND, Ore., Jan. 31, 2026 /PRNewswire/ -- Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for...
Hence then, the article about trace biosciences announces fda ind clearance for first nerve specific imaging agent was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agent )
Also on site :
- Moltbook, a social network where AI agents hang together, may be ‘the most interesting place on the internet right now’
- World Pickleball League 2026: Mumbai Picklepower go down to Bengaluru Jawana despite Brandon Lane's heroics
- INVESTOR DEADLINE: SLM Corporation a/k/a Sallie Mae (SLM) Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces